Effect of precise perioperative anesthesia strategy on prognosis of hepatocellular carcinoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036027

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

control group:Traditional clinical pathway

experimental group:Accurate multivariate monitoring

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Elective liver surgery, ASA I - II grade, aged 18 to 70 years old.

Exclusion criteria

Exclusion criteria: Emergency, critical surgery, ASA III or above, unable to understand or refuse to participate in clinical trials

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;oxygen saturation;PETCO2;train of four stimulation;Central Venous Pressure;blood glucose;blood lactic acid;PH;Ramsay score;pain score;The first feeding time after surgery;blood routine examination;Clotting function;hepatic and renal function;airway pressure;	—

Countries

China

Contacts

Public ContactLu Zhufeng

Zhongshan Hospital, Fudan University

lu.zhufeng@zs-hospital.sh.cn+86 15721258768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026